Masaryk University

Publication Records

česky | in English

Filter publications

    2023

    1. Complex cytogenomic and molecular biological analysis of the tumor genome of patients with myeloid mylignancies with a focus on targeted analysis of the MECOM gene.
      BRYJOVÁ, Lenka, Eva ONDROUŠKOVÁ, Kateřina ČÁBELOVÁ, Jiří ŠMEJKAL, Petra ŠMUHAŘOVÁ, Jana KOTAŠKOVÁ, Andrea MAREČKOVÁ, Michaela BOHÚNOVÁ, Ivana JEŽÍŠKOVÁ, A. FOLTA, Dagmar SMITALOVÁ, Michael DOUBEK, Barbora WEINBERGEROVÁ, Libor ČERVINEK, Anna PANOVSKÁ, Daniela ŽÁČKOVÁ and Marie JAROŠOVÁ. Complex cytogenomic and molecular biological analysis of the tumor genome of patients with myeloid mylignancies with a focus on targeted analysis of the MECOM gene. In EHA-SWG Scientific Meeting on MDS/MPN/AML: Commonalities and Differences of Myeloid Neoplasms, Budapest, Maďarsko. 2023.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 5/1/2024 11:55.
      More: https://is.muni.cz/publication/2356401/en
    2. Germline variant of CTC1 gene in a patient with pulmonary fibrosis and myelodysplastic syndrome
      DOUBKOVÁ, Martina, Zuzana VRZALOVÁ, Marianna ŠTEFÁNIKOVÁ, Libor ČERVINEK, Kateřina STAŇO KOZUBÍK, Ivona BLAHÁKOVÁ, Šárka POSPÍŠILOVÁ and Michael DOUBEK. Germline variant of CTC1 gene in a patient with pulmonary fibrosis and myelodysplastic syndrome. MULTIDISCIPLINARY RESPIRATORY MEDICINE. PAVIA: PAGEPRESS PUBL, 2023, vol. 18, June 2023, p. 1-5. ISSN 1828-695X. Available from: https://dx.doi.org/10.4081/mrm.2023.909.
      URL
      RIV/00216224:14110/23:00131222 Article in a journal. English. Italy.
      Doubková, Martina (203 Czech Republic, guarantor, belonging to the institution) -- Vrzalová, Zuzana (203 Czech Republic, belonging to the institution) -- Štefániková, Marianna (703 Slovakia, belonging to the institution) -- Červinek, Libor (203 Czech Republic, belonging to the institution) -- Staňo Kozubík, Kateřina (203 Czech Republic, belonging to the institution) -- Blaháková, Ivona (203 Czech Republic, belonging to the institution) -- Pospíšilová, Šárka (203 Czech Republic, belonging to the institution) -- Doubek, Michael (203 Czech Republic, belonging to the institution)
      Keywords in English: CTC1 gene; interstitial pulmonary fibrosis; myelodysplastic syndrome
      International impact: yes
      Reviewed: yes
      Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 9/8/2023 08:34.
      More: https://is.muni.cz/publication/2297217/en
    3. Komplexní cytogenomická a molekulárně biologická analýza nádorového genomu pacientů s myeloidními malignitami pacientů s myeloidními malignitami se zaměřením na cílenou analýzu genu MECOM.
      BRYJOVÁ, Lenka, Eva ONDROUŠKOVÁ, Kateřina ČÁBELOVÁ, Jiří ŠMEJKAL, Petra ŠMUHAŘOVÁ, Jana KOTAŠKOVÁ, Andrea MAREČKOVÁ, Michaela BOHÚNOVÁ, Ivana JEŽÍŠKOVÁ, A. FOLTA, Dagmar SMITALOVÁ, Michael DOUBEK, Barbora WEINBERGEROVÁ, Libor ČERVINEK, Anna PANOVSKÁ, Daniela ŽÁČKOVÁ and Marie JAROŠOVÁ. Komplexní cytogenomická a molekulárně biologická analýza nádorového genomu pacientů s myeloidními malignitami pacientů s myeloidními malignitami se zaměřením na cílenou analýzu genu MECOM. In 23. Pražské hematologické dny, Praha. 2023.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 1/2/2023 10:22.
      More: https://is.muni.cz/publication/2251883/en
    4. Myeloidní neoplázie spojeny s cytotoxickou léčbou a jejich souvislost s klonálnou hematopoesou – kazuistika.
      BOHÚNOVÁ, Michaela, Lýdie BRAVENCOVÁ, Marie ZÁDRAPOVÁ, Andrea MAREČKOVÁ, Libor ČERVINEK, Michael DOUBEK, Ivona BLAHÁKOVÁ, Robert HELMA, Jakub HYNŠT, Adam FOLTA, Ivana JEŽÍŠKOVÁ, Šárka POSPÍŠILOVÁ and Jana KOTAŠKOVÁ. Myeloidní neoplázie spojeny s cytotoxickou léčbou a jejich souvislost s klonálnou hematopoesou – kazuistika. In 25. celostátní konference DNA diagnostiky. 2023.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 19/7/2023 13:48.
      More: https://is.muni.cz/publication/2298200/en
    5. The role of clonal hematopoiesis in the development of myeloid neoplasms post cytotoxic therapy - prospective study.
      BOHÚNOVÁ, Michaela, Andrea MAREČKOVÁ, Lenka BRYJOVÁ, Ivona BLAHÁKOVÁ, Robert HELMA, Kamila RÉBLOVÁ, Libor ČERVINEK, Michael DOUBEK, Šárka POSPÍŠILOVÁ and Jana KOTAŠKOVÁ. The role of clonal hematopoiesis in the development of myeloid neoplasms post cytotoxic therapy - prospective study. In EHA-SWG Scientific Meeting on MDS/MPN/AML: Commonalities and Differences of Myeloid Neoplasms, Budapest, Maďarsko. 2023.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 5/1/2024 12:08.
      More: https://is.muni.cz/publication/2356420/en
    6. The role of clonal hematopoiesis variants in the development of myeloid neoplasms post cytotoxic therapy - case series.
      BOHÚNOVÁ, Michaela, Andrea MAREČKOVÁ, Lenka BRYJOVÁ, Ivana JEŽÍŠKOVÁ, A. FOLTA, Šárka PAVLOVÁ, Ivona BLAHÁKOVÁ, Robert HELMA, Jakub HYNŠT, Markéta BEDNAŘÍKOVÁ, Barbora WEINBERGEROVÁ, Libor ČERVINEK, Michael DOUBEK, Šárka POSPÍŠILOVÁ and Jana KOTAŠKOVÁ. The role of clonal hematopoiesis variants in the development of myeloid neoplasms post cytotoxic therapy - case series. In EHA-SWG Scientific Meeting on MDS/MPN/AML: Commonalities and Differences of Myeloid Neoplasms, Budapest, Maďarsko. 2023.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 5/1/2024 12:02.
      More: https://is.muni.cz/publication/2356417/en
    7. Use of thrombopoietin receptor agonists in adults with immune thrombocytopenia: a systematic review and Central European expert consensus
      PULANIC, Drazen, Angelika BATOROVA, Imre BODO, Libor ČERVINEK, Ioana IONITA, Toshko LISSITCHKOV, Anahit MELIKYAN and Maria PODOLAK-DAWIDZIAK. Use of thrombopoietin receptor agonists in adults with immune thrombocytopenia: a systematic review and Central European expert consensus. Annals of hematology. New York: Springer Verlag, 2023, vol. 102, No 4, p. 715-727. ISSN 0939-5555. Available from: https://dx.doi.org/10.1007/s00277-023-05114-8.
      URL
      RIV/00216224:14110/23:00130690 Article in a journal. English. United States of America.
      Pulanic, Drazen (guarantor) -- Červinek, Libor (203 Czech Republic, belonging to the institution)
      Keywords in English: Immune thrombocytopenia; Thrombopoietin receptor agonists; Systematic review; Consensus; Eltrombopag; Romiplostim; Avatrombopag
      International impact: yes
      Reviewed: yes
      Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 2/5/2023 09:35.
      More: https://is.muni.cz/publication/2279440/en

    2022

    1. Complex genomic analysis in myelodysplastic syndrome using combination of molecular cytogenomics and next-generation sequencing approaches.
      BOHÚNOVÁ, Michaela, Andrea MAREČKOVÁ, Libor ČERVINEK, Michael DOUBEK, Marie JAROŠOVÁ, Šárka POSPÍŠILOVÁ and Jana KOTAŠKOVÁ. Complex genomic analysis in myelodysplastic syndrome using combination of molecular cytogenomics and next-generation sequencing approaches. In The BIOMANIA Student Scientific Meeting, Brno. 2022.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 24/11/2022 10:43.
      More: https://is.muni.cz/publication/2233877/en
    2. Komplexní cytogenomická a molekulárně biologická analýza nádorového genomu pacientů s myeloidními malignitami se zaměřením na cílenou analýzu genu MECOM. (Comprehensive cytogenomic and molecular biological analysis of the tumor genome of patients with myeloid malignancies with a focus on targeted analysis of the MECOM gene)
      BRYJOVÁ, Lenka, Eva ONDROUŠKOVÁ, Kateřina ČÁBELOVÁ, Jiří ŠMEJKAL, Petra ŠMUHAŘOVÁ, Jana KOTAŠKOVÁ, Andrea MAREČKOVÁ, Michaela BOHÚNOVÁ, Ivana JEŽÍŠKOVÁ, Adam FOLTA, Dagmar SMITALOVÁ, Michael DOUBEK, Barbora WEINBERGEROVÁ, Libor ČERVINEK, Anna PANOVSKÁ, Daniela ŽÁČKOVÁ and Marie JAROŠOVÁ. Komplexní cytogenomická a molekulárně biologická analýza nádorového genomu pacientů s myeloidními malignitami se zaměřením na cílenou analýzu genu MECOM. (Comprehensive cytogenomic and molecular biological analysis of the tumor genome of patients with myeloid malignancies with a focus on targeted analysis of the MECOM gene). In Celostátní sjezd Společnosti lékařské genetiky a genomiky ČLS JEP a 55. výroční cytogenetická konference, Praha. 2022.
      Name (in English): Comprehensive cytogenomic and molecular biological analysis of the tumor genome of patients with myeloid malignancies with a focus on targeted analysis of the MECOM gene
      RIV/00216224:14110/22:00129710 Conference abstract. Czech. Czech Republic.
      Bryjová, Lenka (203 Czech Republic, belonging to the institution) -- Ondroušková, Eva (203 Czech Republic, belonging to the institution) -- Čábelová, Kateřina (203 Czech Republic, belonging to the institution) -- Šmejkal, Jiří (203 Czech Republic, belonging to the institution) -- Šmuhařová, Petra (203 Czech Republic, belonging to the institution) -- Kotašková, Jana (203 Czech Republic, belonging to the institution) -- Marečková, Andrea (203 Czech Republic, belonging to the institution) -- Bohúnová, Michaela (703 Slovakia, belonging to the institution) -- Ježíšková, Ivana (203 Czech Republic, belonging to the institution) -- Folta, Adam (203 Czech Republic) -- Smitalová, Dagmar (203 Czech Republic, belonging to the institution) -- Doubek, Michael (203 Czech Republic, belonging to the institution) -- Weinbergerová, Barbora (203 Czech Republic, belonging to the institution) -- Červinek, Libor (203 Czech Republic, belonging to the institution) -- Panovská, Anna (203 Czech Republic, belonging to the institution) -- Žáčková, Daniela (203 Czech Republic, belonging to the institution) -- Jarošová, Marie (203 Czech Republic, belonging to the institution)
      Keywords in English: cytogenomic analysis; molecular biological analysis; tumour genome; myeloid malignancies; MECOM
      Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 4/5/2023 13:39.
      More: https://is.muni.cz/publication/2233850/en
    3. Plazmocelulární malignity (mnohočetný myelom, solitární plazmocytom a plazmocelulární leukemie), přehled klinických příznaků, diagnostických kritérií a léčby (Plasma cell neoplasms, multiple myeloma, solitary plasmocytoma a plasma cell leukemia. Clinical symptoms, diagnostic criteria and therapy)
      ADAM, Zdeněk, Luděk POUR, Marta KREJČÍ, David ZEMAN, Eva VLČKOVÁ, Milan KRTIČKA, Pavel ŠLAMPA, Soňa ŠTĚPÁNKOVÁ, Gabriela ROMANOVÁ, Zuzana ADAMOVÁ, Jiří VANÍČEK, Zdeněk ŘEHÁK, Renata KOUKALOVÁ, Veronika MATUŠKOVÁ, Zdeněk KRÁL, Libor ČERVINEK and Viera SANDECKÁ. Plazmocelulární malignity (mnohočetný myelom, solitární plazmocytom a plazmocelulární leukemie), přehled klinických příznaků, diagnostických kritérií a léčby (Plasma cell neoplasms, multiple myeloma, solitary plasmocytoma a plasma cell leukemia. Clinical symptoms, diagnostic criteria and therapy). Onkologie. Olomouc: Solen, s.r.o., 2022, vol. 16, Suppl. B, p. 7-32. ISSN 1802-4475. Available from: https://dx.doi.org/10.36290/xon.2022.054.
      URL
      Name (in English): Plasma cell neoplasms, multiple myeloma, solitary plasmocytoma a plasma cell leukemia. Clinical symptoms, diagnostic criteria and therapy
      RIV/00216224:14110/22:00127294 Article in a journal. Czech. Czech Republic.
      Adam, Zdeněk (203 Czech Republic, belonging to the institution) -- Pour, Luděk (203 Czech Republic, belonging to the institution) -- Krejčí, Marta (203 Czech Republic, belonging to the institution) -- Zeman, David (203 Czech Republic, belonging to the institution) -- Vlčková, Eva (203 Czech Republic, belonging to the institution) -- Krtička, Milan (203 Czech Republic, belonging to the institution) -- Šlampa, Pavel (203 Czech Republic, belonging to the institution) -- Štěpánková, Soňa (203 Czech Republic) -- Romanová, Gabriela (203 Czech Republic, belonging to the institution) -- Adamová, Zuzana (203 Czech Republic) -- Vaníček, Jiří (203 Czech Republic, belonging to the institution) -- Řehák, Zdeněk (203 Czech Republic) -- Koukalová, Renata (203 Czech Republic) -- Matušková, Veronika (203 Czech Republic) -- Král, Zdeněk (203 Czech Republic, belonging to the institution) -- Červinek, Libor (203 Czech Republic, belonging to the institution) -- Sandecká, Viera (703 Slovakia, belonging to the institution)
      Keywords in English: multiple myeloma; solitary plasmocytoma; plasma cell leukemia; daratumumab; bone marrow transplantation
      Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 29/11/2022 12:59.
      More: https://is.muni.cz/publication/2235448/en

    2021

    1. Alelická kompozícia génu BCOR u pacientov s myelodysplastickým syndrómom.
      BOHÚNOVÁ, Michaela, Andrea MAREČKOVÁ, Lenka BRYJOVÁ, Jakub HYNŠT, Marcela ŽENATOVÁ, Šárka POSPÍŠILOVÁ, Michael DOUBEK, Libor ČERVINEK, Marie JAROŠOVÁ and Jana KOTAŠKOVÁ. Alelická kompozícia génu BCOR u pacientov s myelodysplastickým syndrómom. In II. Český hematologický a transfuziologický sjezd v Transfuze a Hematologie Dnes (2021). 2021.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 18/12/2021 10:01.
      More: https://is.muni.cz/publication/1811799/en
    2. Detekce transpozibilních elementů u hematologických malignit.
      PLEVOVÁ, Karla, Šárka PAVLOVÁ, Anastasiya VOLAKHAVA, Marcela KRZYŽÁNKOVÁ, Hana SYNÁČKOVÁ, Hana JELÍNKOVÁ, Marcela ŽENATOVÁ, Michaela BOHÚNOVÁ, Tomáš LOJA, Michael DOUBEK, Libor ČERVINEK, Jana KOTAŠKOVÁ, Jiří MAYER, Šárka POSPÍŠILOVÁ and Ilgar MAMEDOV. Detekce transpozibilních elementů u hematologických malignit. In II. Český hematologický a transfuziologický sjezd v Transfuze a Hematologie Dnes (2021). 2021.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 20/12/2021 08:16.
      More: https://is.muni.cz/publication/1812427/en
    3. Význam použitia panelového NGS testovania u myelodysplastického syndrómu.
      BOHÚNOVÁ, Michaela, Andrea MAREČKOVÁ, Lenka BRYJOVÁ, Jakub HYNŠT, Marcela ŽENATOVÁ, Šárka POSPÍŠILOVÁ, Michael DOUBEK, Libor ČERVINEK, Marie JAROŠOVÁ and Jana KOTAŠKOVÁ. Význam použitia panelového NGS testovania u myelodysplastického syndrómu. In II. Český hematologický a transfuziologický sjezd v Transfuze a Hematologie Dnes. 2021.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 2/2/2022 14:02.
      More: https://is.muni.cz/publication/1830782/en

    2020

    1. NGS u MDS - praktické aspekty
      ČERVINEK, Libor, Jana KOTAŠKOVÁ and Michael DOUBEK. NGS u MDS - praktické aspekty. In Novinky v hematologii. 2020.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 4/1/2021 14:42.
      More: https://is.muni.cz/publication/1718096/en
    2. Ropeginterferon alfa-2 b v léčbě pacientů s pravou polycytémií (Ropeginterferon alfa-2 b for the therapy of polycythemia vera)
      ČERVINEK, Libor. Ropeginterferon alfa-2 b v léčbě pacientů s pravou polycytémií (Ropeginterferon alfa-2 b for the therapy of polycythemia vera). Vnitřní lékařství. Praha: Česká lékařská společnost J. E. Purkyně, 2020, vol. 66, No 5, p. 309-313. ISSN 0042-773X.
      URL
      Name (in English): Ropeginterferon alfa-2 b for the therapy of polycythemia vera
      RIV/00216224:14110/20:00118144 Article in a journal. Czech. Czech Republic.
      Červinek, Libor (203 Czech Republic, guarantor, belonging to the institution)
      Keywords in English: ropeginterferon alfa-2 b; myeloproliferative neoplasms; PROUD-PV; CONTINUATION-PV
      Reviewed: yes
      Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 31/3/2021 12:34.
      More: https://is.muni.cz/publication/1740557/en

    2019

    1. Deficiency and haploinsufficiency of histone macroH2A1.1 in mice recapitulate hematopoietic defects of human myelodysplastic syndrome
      BERESHCHENKO, Oxana, Oriana LO RE, Fedor NIKULENKOV, Sara FLAMINI, Jana KOTAŠKOVÁ, Tommaso MAZZA, Marguerite-Mari LE PANNERER, Marcus BUSCHBECK, Cesarina GIALLONGO, Giuseppe PALUMBO, Giovanni LI VOLTI, Valerio PAZIENZA, Libor ČERVINEK, Carlo RICCARDI, Lumír KREJČÍ, Šárka POSPÍŠILOVÁ, A. Francis STEWART and Manlio VINCIGUERRA. Deficiency and haploinsufficiency of histone macroH2A1.1 in mice recapitulate hematopoietic defects of human myelodysplastic syndrome. CLINICAL EPIGENETICS. LONDON: BMC, 2019, vol. 11, No 1, p. 1-14. ISSN 1868-7075. Available from: https://dx.doi.org/10.1186/s13148-019-0724-z.
      URL
      RIV/00216224:14740/19:00108045 Article in a journal. English. United Kingdom of Great Britain and Northern Ireland.
      Bereshchenko, Oxana (380 Italy, guarantor) -- Lo Re, Oriana (380 Italy, belonging to the institution) -- Nikulenkov, Fedor (203 Czech Republic, belonging to the institution) -- Flamini, Sara (380 Italy) -- Kotašková, Jana (203 Czech Republic, belonging to the institution) -- Mazza, Tommaso (380 Italy) -- Le Pannerer, Marguerite-Mari (724 Spain) -- Buschbeck, Marcus (724 Spain) -- Giallongo, Cesarina (380 Italy) -- Palumbo, Giuseppe (380 Italy) -- Li Volti, Giovanni (380 Italy) -- Pazienza, Valerio (380 Italy) -- Červinek, Libor (203 Czech Republic, belonging to the institution) -- Riccardi, Carlo (380 Italy) -- Krejčí, Lumír (203 Czech Republic, belonging to the institution) -- Pospíšilová, Šárka (203 Czech Republic, belonging to the institution) -- Stewart, A. Francis (276 Germany) -- Vinciguerra, Manlio (380 Italy)
      Keywords in English: Hematopoiesis; Myelodysplastic syndrome
      International impact: yes
      Reviewed: yes
      Changed by: Mgr. Pavla Foltynová, Ph.D., učo 106624. Changed: 31/3/2020 21:29.
      More: https://is.muni.cz/publication/1604822/en
    2. Detekce somatických variant u myelodysplastického syndromu: srovnání tří odlišných postupů při přípravě sekvenačních knihoven pro vyšetření panelu genů.
      KOTAŠKOVÁ, Jana, Andrea MAREČKOVÁ, Jiří ŠTIKA, Jakub HYNŠT, Šárka PAVLOVÁ, Martina VALIŠOVÁ, Marcela ŽENATOVÁ, Hana SVOZILOVÁ, Kristýna ZÁVACKÁ, Marie JAROŠOVÁ, Libor ČERVINEK, Michael DOUBEK and Šárka POSPÍŠILOVÁ. Detekce somatických variant u myelodysplastického syndromu: srovnání tří odlišných postupů při přípravě sekvenačních knihoven pro vyšetření panelu genů. In 23. celostátní konference DNA diagnostiky, Brno. 2019.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 29/1/2020 08:09.
      More: https://is.muni.cz/publication/1613219/en
    3. Pancytopenie, panhypopituitarizmus a jaterní cirhóza: rozbor složité kazuistiky (Pancytopenia, panhypopituitarism and liver cirrhosis: analysis of a difficult clinical case)
      POLÁK, Pavel, Jan KAMELANDER, Jana MICHALCOVÁ, Jiřina ZAVŘELOVÁ, Libor ČERVINEK, Tomáš ROHAN, Zuzana PAZDIČOVÁ, Václav ODSTRČILÍK and Miroslav PENKA. Pancytopenie, panhypopituitarizmus a jaterní cirhóza: rozbor složité kazuistiky (Pancytopenia, panhypopituitarism and liver cirrhosis: analysis of a difficult clinical case). Vnitřní lékařství. 2019, vol. 2019, No 11, p. 715-720, 5 pp. ISSN 0042-773X.
      Name in Czech: Pancytopenie, panhypopituitarizmus a jaterní cirhóza: rozbor složité kazuistiky
      Name (in English): Pancytopenia, panhypopituitarism and liver cirrhosis: analysis of a difficult clinical case

      Keywords in English: liver cirrhosis; coagulopathy; pancytopenia; panhypopituitarism
      Reviewed: yes
      Changed by: MUDr. Pavel Polák, Ph.D., učo 108316. Changed: 13/1/2020 15:45.
      More: https://is.muni.cz/publication/1603336/en

    2018

    1. Verification of Survival Predictors in Elderly Patients with Myelodysplastic Syndrome from Outpatient Clinical Practice
      KADLČKOVÁ, Eva, Peter ROHOŇ, Tomáš FÜRST, Libor ČERVINEK, Andrea JONÁŠOVÁ, Tomáš ŠÁLEK, Jiří TESAŘ and Yvetta STAVAŘOVÁ. Verification of Survival Predictors in Elderly Patients with Myelodysplastic Syndrome from Outpatient Clinical Practice. INTERNATIONAL JOURNAL OF GERONTOLOGY. TAIPEI: ELSEVIER TAIWAN, 2018, vol. 12, No 1, p. 27-31. ISSN 1873-9598. Available from: https://dx.doi.org/10.1016/j.ijge.2017.06.001.
      RIV/00216224:14110/18:00104088 Article in a journal. English. Czech Republic.
      Kadlčková, Eva (203 Czech Republic, guarantor) -- Rohoň, Peter (203 Czech Republic) -- Fürst, Tomáš (203 Czech Republic) -- Červinek, Libor (203 Czech Republic, belonging to the institution) -- Jonášová, Andrea (203 Czech Republic) -- Šálek, Tomáš (203 Czech Republic) -- Tesař, Jiří (203 Czech Republic) -- Stavařová, Yvetta (203 Czech Republic)
      Keywords in English: chelation therapy; myelodysplastic syndrome; prognostic scoring system; transfusion
      International impact: yes
      Reviewed: yes
      Changed by: Soňa Böhmová, učo 232884. Changed: 11/2/2019 15:55.
      More: https://is.muni.cz/publication/1451477/en

    2017

    1. Hematologie (Hematology)
      DOUBEK, Michael, Zdeněk ADAM, Zdeňka ČERMÁKOVÁ, Libor ČERVINEK, Martina DOUBKOVÁ, František FOLBER, Markéta HADRABOVÁ, Andrea JANÍKOVÁ, Jarmila KISSOVÁ, Marta KREJČÍ, Daniel LYSÁK, Miloslava MATÝŠKOVÁ, Tomáš NEBESKÝ, Luděk POUR and Daniela ŽÁČKOVÁ. Hematologie (Hematology). 1. vyd. Brno: Masarykova univerzita, 2017, 306 pp. ISBN 978-80-210-8776-7.
      URL
      Name (in English): Hematology
      RIV/00216224:14110/17:00098799 Textbook. Oncology and haematology. Czech. Czech Republic.
      Doubek, Michael (203 Czech Republic, guarantor, belonging to the institution) -- Adam, Zdeněk (203 Czech Republic, belonging to the institution) -- Čermáková, Zdeňka (203 Czech Republic) -- Červinek, Libor (203 Czech Republic, belonging to the institution) -- Doubková, Martina (203 Czech Republic, belonging to the institution) -- Folber, František (203 Czech Republic, belonging to the institution) -- Hadrabová, Markéta (203 Czech Republic, belonging to the institution) -- Janíková, Andrea (203 Czech Republic, belonging to the institution) -- Kissová, Jarmila (203 Czech Republic) -- Krejčí, Marta (203 Czech Republic, belonging to the institution) -- Lysák, Daniel (203 Czech Republic) -- Matýšková, Miloslava (203 Czech Republic) -- Nebeský, Tomáš (203 Czech Republic) -- Pour, Luděk (203 Czech Republic, belonging to the institution) -- Žáčková, Daniela (203 Czech Republic, belonging to the institution)
      Keywords in English: hematology
      Changed by: Soňa Böhmová, učo 232884. Changed: 3/2/2018 17:18.
      More: https://is.muni.cz/publication/1399258/en
    2. Hematologie. Pomocník ke stážím na hematologických pracovištích
      DOUBEK, Michael, Zdeněk ADAM, Zdeňka ČERMÁKOVÁ, Libor ČERVINEK, Martina DOUBKOVÁ, František FOLBER, Markéta HADRABOVÁ, Andrea JANÍKOVÁ, Jarmila KISSOVÁ, Marta KREJČÍ, Daniel LYSÁK, Miloslava MATÝŠKOVÁ, Tomáš NEBESKÝ, Luděk POUR and Daniela ŽÁČKOVÁ. Hematologie. Pomocník ke stážím na hematologických pracovištích. 1st ed. Brno: Masarykova univerzita, 2017. ISBN 978-80-210-8776-7.
      Oncology and haematology. Czech. Czech Republic.
      Changed by: Mgr. Radka Vyskočilová, učo 2368. Changed: 6/11/2017 11:48.
      More: https://is.muni.cz/publication/1394393/en
    3. Zkušenosti s léčbou ruxolitinibem u pacientu s myelofibrózou a pravou polycytemií na českých hematologických pracovištích (Experience with ruxolitinib in the treatment of myelofibrosis and polycythaemia vera at Czech haematological institutions)
      WEINBERGEROVÁ, Barbora, Petra ČIČÁTKOVÁ, M. PALOVÁ, L. STEJSKAL, P. BĚLOHLÁVKOVÁ, Jarmila KISSOVÁ, L. WALTEROVÁ, H. FRAŇKOVÁ, O. ČERNÁ, L. LAKOMÁ, Martin BREJCHA, J. PELKOVÁ, M. SCHÜTZOVÁ, J. OBERNAUEROVÁ, D. NECHVÍLOVÁ, E. BOGOCZOVÁ, A. HLUŠÍ, E. FABER, Miroslav PENKA, Yvona BRYCHTOVÁ, Libor ČERVINEK, Michael DOUBEK, P. ŽÁK, Jiří MAYER and Zdeněk RÁČIL. Zkušenosti s léčbou ruxolitinibem u pacientu s myelofibrózou a pravou polycytemií na českých hematologických pracovištích (Experience with ruxolitinib in the treatment of myelofibrosis and polycythaemia vera at Czech haematological institutions). Transfuze a hematologie dnes. Praha: Česká lékařská společnost J.E. Purkyně, 2017, vol. 23, No 1, p. 30-40. ISSN 1213-5763.
      Name (in English): Experience with ruxolitinib in the treatment of myelofibrosis and polycythaemia vera at Czech haematological institutions
      RIV/00216224:14110/17:00097374 Article in a journal. Oncology and haematology. Czech. Czech Republic.
      Weinbergerová, Barbora (203 Czech Republic, guarantor, belonging to the institution) -- Čičátková, Petra (203 Czech Republic, belonging to the institution) -- Palová, M. (203 Czech Republic) -- Stejskal, L. (203 Czech Republic) -- Bělohlávková, P. (203 Czech Republic) -- Kissová, Jarmila (203 Czech Republic) -- Walterová, L. (203 Czech Republic) -- Fraňková, H. (203 Czech Republic) -- Černá, O. (203 Czech Republic) -- Lakomá, L. (203 Czech Republic) -- Brejcha, Martin (203 Czech Republic) -- Pelková, J. (203 Czech Republic) -- Schützová, M. (203 Czech Republic) -- Obernauerová, J. (203 Czech Republic) -- Nechvílová, D. (203 Czech Republic) -- Bogoczová, E. (203 Czech Republic) -- Hluší, A. (203 Czech Republic) -- Faber, E. (203 Czech Republic) -- Penka, Miroslav (203 Czech Republic) -- Brychtová, Yvona (203 Czech Republic, belonging to the institution) -- Červinek, Libor (203 Czech Republic) -- Doubek, Michael (203 Czech Republic, belonging to the institution) -- Žák, P. (203 Czech Republic) -- Mayer, Jiří (203 Czech Republic, belonging to the institution) -- Ráčil, Zdeněk (203 Czech Republic, belonging to the institution)
      Keywords in English: Drug toxicity; Myelofibrosis; Polycythaemia vera; Ruxolitinib; Treatment outcome
      International impact: yes
      Reviewed: yes
      Changed by: Soňa Böhmová, učo 232884. Changed: 22/3/2018 15:32.
      More: https://is.muni.cz/publication/1387803/en

    2016

    1. Analýza mutací v genu TP53 u MDS pacientů
      KOTAŠKOVÁ, Jana, Šárka PAVLOVÁ and Libor ČERVINEK. Analýza mutací v genu TP53 u MDS pacientů. In 6. zimní setkání Czech MDS Group. 2016.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 6/3/2017 15:34.
      More: https://is.muni.cz/publication/1374806/en
    2. Changes in bone marrow morphology in adults receiving romiplostim for the treatment of thrombocytopenia associated with primary immune thrombocytopenia
      JANSSENS, A., F. RODEGHIERO, D. ANDERSON, B.H. CHONG, Z. BODA, I. PABINGER, Libor ČERVINEK, D.R. TERRELL, X.N. WANG and J. FRANKLIN. Changes in bone marrow morphology in adults receiving romiplostim for the treatment of thrombocytopenia associated with primary immune thrombocytopenia. Annals of hematology. Berlin: Springer Verlag, 2016, vol. 95, No 7, p. 1077-1087. ISSN 0939-5555. Available from: https://dx.doi.org/10.1007/s00277-016-2682-2.
      RIV/00216224:14110/16:00093965 Article in a journal. Oncology and haematology. English. United States of America.
      Janssens, A. (56 Belgium) -- Rodeghiero, F. (380 Italy) -- Anderson, D. (124 Canada) -- Chong, B.H. (36 Australia) -- Boda, Z. (348 Hungary) -- Pabinger, I. (40 Austria) -- Červinek, Libor (203 Czech Republic, guarantor, belonging to the institution) -- Terrell, D.R. (840 United States of America) -- Wang, X.N. (840 United States of America) -- Franklin, J. (840 United States of America)
      Keywords in English: Immune thrombocytopenia (ITP); Thrombopoietin (TPO); Platelet; Bone marrow; Reticulin; Collagen
      International impact: yes
      Reviewed: yes
      Changed by: Soňa Böhmová, učo 232884. Changed: 23/3/2017 12:00.
      More: https://is.muni.cz/publication/1376235/en
    3. Sinusová histiocytóza s masivní lymfadenopatií: FDG-PET/CT dokumentovaná parciální remise po léčbě 2-chlorodeoxyadenozinem (Sinus histiocytosis with massive lymphadenopathy: FDC-PET/CT documented partial remission after treatment with 2-chlorodeoxyadenosine)
      ADAM, Zdeněk, Jiří MAŠLAŇ, Leoš KŘEN, Roman KODET, Renata KOUKALOVÁ, Zdeněk ŘEHÁK, Libor ČERVINEK, Luděk POUR, Marta KREJČÍ, Viera SANDECKÁ, Zdeněk KRÁL and Jiří MAYER. Sinusová histiocytóza s masivní lymfadenopatií: FDG-PET/CT dokumentovaná parciální remise po léčbě 2-chlorodeoxyadenozinem (Sinus histiocytosis with massive lymphadenopathy: FDC-PET/CT documented partial remission after treatment with 2-chlorodeoxyadenosine). Vnitřní lékařství. Praha: Česká lékařská společnost J.E. Purkyně, 2016, vol. 62, No 6, p. 491-499. ISSN 0042-773X.
      Name (in English): Sinus histiocytosis with massive lymphadenopathy: FDC-PET/CT documented partial remission after treatment with 2-chlorodeoxyadenosine
      RIV/00216224:14110/16:00088949 Article in a journal. Oncology and haematology. Czech. Czech Republic.
      Adam, Zdeněk (203 Czech Republic, guarantor, belonging to the institution) -- Mašlaň, Jiří (203 Czech Republic) -- Křen, Leoš (203 Czech Republic, belonging to the institution) -- Kodet, Roman (203 Czech Republic) -- Koukalová, Renata (203 Czech Republic) -- Řehák, Zdeněk (203 Czech Republic) -- Červinek, Libor (203 Czech Republic, belonging to the institution) -- Pour, Luděk (203 Czech Republic, belonging to the institution) -- Krejčí, Marta (203 Czech Republic, belonging to the institution) -- Sandecká, Viera (703 Slovakia, belonging to the institution) -- Král, Zdeněk (203 Czech Republic, belonging to the institution) -- Mayer, Jiří (203 Czech Republic, belonging to the institution)
      Keywords in English: Castleman's disease; lenalidomide; Rosai-Dorfman disease; rituximab; sinus lymphadenopathy with massive lymphadenopathy; thalidomide; 2-chlorodeoxyadenosine
      International impact: yes
      Reviewed: yes
      Changed by: Soňa Böhmová, učo 232884. Changed: 9/2/2017 14:21.
      More: https://is.muni.cz/publication/1371911/en
    4. Thrombosis in thrombocythemic Ph-myeloproliferations is associated with higher platelet count prior to the event: results of analyses of prothrombotic risk factors from a registry of patients treated with anagrelide
      SCHWARZ, Jiří, Petra OVESNÁ, Olga ČERNÁ, Jarmila KISSOVÁ, Jacqueline SOUKUPOVÁ MAALOUFOVÁ, Yvona BRYCHTOVÁ, Michael DOUBEK, Libor ČERVINEK, Eduard CMUNT, Petr DULÍČEK, Vít CAMPR, Leoš KŘEN and Miroslav PENKA. Thrombosis in thrombocythemic Ph-myeloproliferations is associated with higher platelet count prior to the event: results of analyses of prothrombotic risk factors from a registry of patients treated with anagrelide. European Journal of Haematology. Hoboken: Wiley-Blackwell, 2016, vol. 96, No 1, p. 98-106. ISSN 0902-4441. Available from: https://dx.doi.org/10.1111/ejh.12554.
      Name (in English): Thrombosis in thrombocythemic Ph-myeloproliferations is associated with higher platelet count prior to the event: results of analyses of prothrombotic risk factors from a registry of patients treated with anagrelide
      RIV/00216224:14110/16:00089657 Article in a journal. Oncology and haematology. English. United States of America.
      Schwarz, Jiří (203 Czech Republic) -- Ovesná, Petra (203 Czech Republic, belonging to the institution) -- Černá, Olga (203 Czech Republic) -- Kissová, Jarmila (203 Czech Republic, belonging to the institution) -- Soukupová Maaloufová, Jacqueline (203 Czech Republic) -- Brychtová, Yvona (203 Czech Republic) -- Doubek, Michael (203 Czech Republic, belonging to the institution) -- Červinek, Libor (203 Czech Republic, belonging to the institution) -- Cmunt, Eduard (203 Czech Republic) -- Dulíček, Petr (203 Czech Republic) -- Campr, Vít (203 Czech Republic) -- Křen, Leoš (203 Czech Republic, belonging to the institution) -- Penka, Miroslav (203 Czech Republic, guarantor, belonging to the institution)
      Keywords in English: myeloproliferative disorders; platelets; JAK2; thrombophilia; thrombosis; anagrelide
      International impact: yes
      Reviewed: yes
      Changed by: Ing. Mgr. Věra Pospíšilíková, učo 9005. Changed: 4/8/2016 16:32.
      More: https://is.muni.cz/publication/1341786/en

    2015

    1. Diagnostika a léčba PH negativních myeloproliferativních neoplázií na českých hematologických pracovištích - analýza MIND (Myeloproliferative Neoplasia Database)
      WEINBERGEROVÁ, Barbora, Petra ČIČÁTKOVÁ, Jana STRENKOVÁ, Lenka PAVLOVSKÁ, P BĚLOHLÁVKOVÁ, P ŽÁK, M PALOVÁ, A HLUŠÍ, D LYSÁK, M BREJCHA, Libor ČERVINEK, Yvona BRYCHTOVÁ, Michael DOUBEK, Jiří MAYER and Zdeněk RÁČIL. Diagnostika a léčba PH negativních myeloproliferativních neoplázií na českých hematologických pracovištích - analýza MIND (Myeloproliferative Neoplasia Database). In XVII. slovensko-český hematologický a transfuziologický zjazd s medzinárodnou účasťou, 24.-27.9.2015, Bratislava in Interná Medicína, abstrakty prednášok, Suppl. 15/2015, str.105-106. 2015.

      Type of participation: active participation (giving a lecture, organization, etc.)
      Changed by: prof. MUDr. Zdeněk Ráčil, Ph.D., učo 18831. Changed: 3/2/2016 11:02.
      More: https://is.muni.cz/publication/1333993/en
    2. Myelodysplastický syndrom
      ČERVINEK, Libor. Myelodysplastický syndrom. In Jiří Tomášek. Onkologie : minimum pro praxi. 1. vyd. Praha: Axonite CZ, 2015, p. 364-372. Asclepius. ISBN 978-80-88046-01-1.
      Oncology and haematology. Czech. Czech Republic.
      Changed by: Ing. Mgr. Věra Pospíšilíková, učo 9005. Changed: 5/1/2016 09:57.
      More: https://is.muni.cz/publication/1322778/en
    3. Sustained remission of chronic immune thrombocytopenia after discontinuation of treatment with thrombopoietin-receptor agonists in adults
      ČERVINEK, Libor, Jiří MAYER and Michael DOUBEK. Sustained remission of chronic immune thrombocytopenia after discontinuation of treatment with thrombopoietin-receptor agonists in adults. International journal of hematology. Tokyo: Springer Japan KK, 2015, vol. 102, No 1, p. 7-11. ISSN 0925-5710. Available from: https://dx.doi.org/10.1007/s12185-015-1793-1.
      URL
      RIV/00216224:14740/15:00085026 Article in a journal. Oncology and haematology. English. Japan.
      Červinek, Libor (203 Czech Republic, belonging to the institution) -- Mayer, Jiří (203 Czech Republic, belonging to the institution) -- Doubek, Michael (203 Czech Republic, guarantor, belonging to the institution)
      Keywords in English: Immune thrombocytopenia; Thrombopoietin-receptor agonists; Remission; Sustained response
      International impact: yes
      Reviewed: yes
      Changed by: Mgr. Eva Špillingová, učo 110713. Changed: 4/4/2016 13:48.
      More: https://is.muni.cz/publication/1319527/en
    4. Zkušenosti s léčbou ruxolitinibem (JAKAVI) u pacientů s myelofibrózou na českých hematologických pracovištích.
      WEINBERGEROVÁ, Barbora, Zdeněk RÁČIL, M PALOVÁ, A HLUŠÍ, E FABER, L STEJSKAL, J KISSOVÁ, O ČERNÁ, M BREJCHA, M SCHUTZOVÁ, J OBERNAUEROVÁ, D NECHVÍLOVÁ, L WALTEROVÁ, H FRAŇKOVÁ, E BOGOCZOVÁ, J PELKOVÁ, L LAKOMÁ, Miroslav PENKA, R HÁJEK, Libor ČERVINEK, Yvona BRYCHTOVÁ, Michael DOUBEK and Jiří MAYER. Zkušenosti s léčbou ruxolitinibem (JAKAVI) u pacientů s myelofibrózou na českých hematologických pracovištích. In XVII. slovensko-český hematologický a transfuziologický zjazd s medzinárodnou účasťou, 24.-27.9.2015, Bratislava in Interná Medicína, abstrakty prednášok, Suppl. 15/2015, str.64-65. 2015.

      Type of participation: active participation (giving a lecture, organization, etc.)
      Changed by: prof. MUDr. Zdeněk Ráčil, Ph.D., učo 18831. Changed: 3/2/2016 11:08.
      More: https://is.muni.cz/publication/1333994/en

    2014

    1. Differential Diagnosis of Thrombocytopenia
      ČERVINEK, Libor and Michael DOUBEK. Differential Diagnosis of Thrombocytopenia. In Mckenzie G. Bell. Thrombocytopenia. New York: Nova Science Publishers, 2014, p. 91-96. ISBN 978-1-63321-713-3.
      RIV/00216224:14740/14:00082539 Chapter(s) of a specialized book. Oncology and haematology. English. United States of America.
      Červinek, Libor (203 Czech Republic, belonging to the institution) -- Doubek, Michael (203 Czech Republic, guarantor, belonging to the institution)
      Keywords in English: Thrombocytopenia; diagnosing ITP; Myelodysplastic Syndromes
      International impact: yes
      Reviewed: yes
      Changed by: Mgr. Eva Špillingová, učo 110713. Changed: 19/4/2016 10:06.
      More: https://is.muni.cz/publication/1230719/en
    2. JAK2 inhibitory v léčbě primární myelofibrózy. Dodatek k doporučením pro diagnostiku a léčbu Ph negativních myeloproliferativních onemocnění České pracovní skupiny pro Ph negativní myeloproliferativní onemocnění České hematologické společnosti ČLS JEP (CZEMP) (The place of JAK2 inhibitors in the treatment of myelofibrosis. Ad amendment to the recommendations for diagnosis and treatment of Ph negative myeloproliferations of the Czech group for Ph-myeloproliferative disorders (CZEMP))
      ČERVINEK, Libor, Michael DOUBEK, Miroslav PENKA and Jiří SCHWARZ. JAK2 inhibitory v léčbě primární myelofibrózy. Dodatek k doporučením pro diagnostiku a léčbu Ph negativních myeloproliferativních onemocnění České pracovní skupiny pro Ph negativní myeloproliferativní onemocnění České hematologické společnosti ČLS JEP (CZEMP) (The place of JAK2 inhibitors in the treatment of myelofibrosis. Ad amendment to the recommendations for diagnosis and treatment of Ph negative myeloproliferations of the Czech group for Ph-myeloproliferative disorders (CZEMP)). Vnitřní lékařství. Brno: Facta Medica, 2014, vol. 60, No 2, p. 158-163. ISSN 0042-773X.
      Name (in English): The place of JAK2 inhibitors in the treatment of myelofibrosis. Ad amendment to the recommendations for diagnosis and treatment of Ph negative myeloproliferations of the Czech group for Ph-myeloproliferative disorders (CZEMP)
      RIV/00216224:14110/14:00079313 Article in a journal. Pneumology. Czech. Czech Republic.
      Červinek, Libor (203 Czech Republic, guarantor, belonging to the institution) -- Doubek, Michael (203 Czech Republic, belonging to the institution) -- Penka, Miroslav (203 Czech Republic, belonging to the institution) -- Schwarz, Jiří (203 Czech Republic)
      Keywords in English: JAK2 inhibitors; ruxolitinib; Ph negative myeloproliferative diseases; myeloproliferative diseases; myeloproliferative neoplasia; primary myelofibrosis; treatment recommendations
      Reviewed: yes
      Changed by: Ing. Mgr. Věra Pospíšilíková, učo 9005. Changed: 2/3/2015 16:31.
      More: https://is.muni.cz/publication/1228783/en

    2013

    1. A comparative study of deferasirox and deferiprone in the treatment of iron overload in patients with myelodysplastic syndromes
      CERMAK, Jaroslav, Anna JONASOVA, Jana VONDRAKOVA, Libor ČERVINEK, Petra BELOHLAVKOVA and Radana NEUWIRTOVA. A comparative study of deferasirox and deferiprone in the treatment of iron overload in patients with myelodysplastic syndromes. Leukemia Research. OXFORD: PERGAMON-ELSEVIER SCIENCE LTD, 2013, vol. 37, No 12, p. 1612-1615. ISSN 0145-2126. Available from: https://dx.doi.org/10.1016/j.leukres.2013.07.021.
      Name (in English): A comparative study of deferasirox and deferiprone in the treatment of iron overload in patients with myelodysplastic syndromes
      RIV/00216224:14110/13:00071203 Article in a journal. Oncology and haematology. English. United Kingdom of Great Britain and Northern Ireland.
      Cermak, Jaroslav (203 Czech Republic) -- Jonasova, Anna (203 Czech Republic) -- Vondrakova, Jana (203 Czech Republic) -- Červinek, Libor (203 Czech Republic, guarantor, belonging to the institution) -- Belohlavkova, Petra (203 Czech Republic) -- Neuwirtova, Radana (203 Czech Republic)
      Keywords in English: Deferiprone; Deferasirox;Chelation; Myelodysplasia; Toxicity; Side effects
      International impact: yes
      Reviewed: yes
      Changed by: Soňa Böhmová, učo 232884. Changed: 21/1/2014 11:36.
      More: https://is.muni.cz/publication/1160194/en
    2. Klonální evoluce u myeloproliferativních neoplazií a role genu TP53
      PAVLOVÁ, Šárka, Blanka KUBEŠOVÁ, Libor ČERVINEK, Michael DOUBEK and Šárka POSPÍŠILOVÁ. Klonální evoluce u myeloproliferativních neoplazií a role genu TP53. In VIII. Brněnské hematologické dny. 2013.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 8/1/2014 23:11.
      More: https://is.muni.cz/publication/1139183/en
    3. Nemoc chladových aglutininů nereagující na léčbu glukokortikoidy a na léčbu rituximabem. Jaký postup zvolit pro III. linii léčby? Popis případu a přehled literatury (Cold agglutinin disease - No response to glucocorticoids and rituximab, what treatment is best for the 3rd line of therapy? Case report and review of the literature)
      ADAM, Zdeněk, A. PEJCHALOVÁ, G. CHLUPOVÁ, L. ŘÍHOVÁ, Luděk POUR, Marta KREJČÍ, Libor ČERVINEK, Zdeněk KRÁL and Jiří MAYER. Nemoc chladových aglutininů nereagující na léčbu glukokortikoidy a na léčbu rituximabem. Jaký postup zvolit pro III. linii léčby? Popis případu a přehled literatury (Cold agglutinin disease - No response to glucocorticoids and rituximab, what treatment is best for the 3rd line of therapy? Case report and review of the literature). Vnitřní lékařství. Brno: Ambit Media a.s., 2013, vol. 59, No 9, p. 828-840. ISSN 0042-773X.
      Name (in English): Cold agglutinin disease - No response to glucocorticoids and rituximab, what treatment is best for the 3rd line of therapy? Case report and review of the literature
      RIV/00216224:14110/13:00065644 Article in a journal. Oncology and haematology. Czech. Czech Republic.
      Adam, Zdeněk (203 Czech Republic, guarantor, belonging to the institution) -- Pejchalová, A. (203 Czech Republic) -- Chlupová, G. (203 Czech Republic) -- Říhová, L. (203 Czech Republic) -- Pour, Luděk (203 Czech Republic, belonging to the institution) -- Krejčí, Marta (203 Czech Republic, belonging to the institution) -- Červinek, Libor (203 Czech Republic, belonging to the institution) -- Král, Zdeněk (203 Czech Republic, belonging to the institution) -- Mayer, Jiří (203 Czech Republic)
      Keywords in English: Autoimmune haemolytic anaemia; Bendamustin; Bortezomib; Cold agglutinin disease; Cyclophosphamide; Eculizumab; Fludarabin; Rituximab; Waldenström macroglobulinemia
      Reviewed: yes
      Changed by: Soňa Böhmová, učo 232884. Changed: 17/12/2013 11:39.
      More: https://is.muni.cz/publication/1137311/en
    4. První zkušenosti České MDS skupiny s terapií 5-azacytidinem u nemocných s myelodysplastickým syndromem s vyšším rizikem (IPSS střední 2 a vysoké riziko), akutní myeloidní leukemií do 30 % myeloblastů a chronickou myelomonocytární leukemií II (Initial experience of Czech MDS Group with 5-azacytidine in patients with high risk myelodysplastic syndromes (IPSS intermediate II and high), acute myeloid leukaemia with less than 30% myeloblasts and chronic myelomonocytic leukaemia II)
      JONÁŠOVÁ, A., J. ČERMÁK, Libor ČERVINEK, L. NOVÁKOVÁ, P. BĚLOHLÁVKOVÁ, J. VONDRÁKOVÁ, O. ČERNÁ, M. SÝKORA, N. SEIFERTOVÁ, L. WALTEROVÁ, J. LIBIGER, I. HOCHOVÁ, J. ULLRYCHOVÁ, P. ROHOŇ, J. OBERNAUEROVÁ, M. SCHUTZOVÁ, V. VOZOBULOVÁ, H. POLÁČKOVÁ, K. KAČMÁŘOVÁ and Jan MUŽÍK. První zkušenosti České MDS skupiny s terapií 5-azacytidinem u nemocných s myelodysplastickým syndromem s vyšším rizikem (IPSS střední 2 a vysoké riziko), akutní myeloidní leukemií do 30 % myeloblastů a chronickou myelomonocytární leukemií II (Initial experience of Czech MDS Group with 5-azacytidine in patients with high risk myelodysplastic syndromes (IPSS intermediate II and high), acute myeloid leukaemia with less than 30% myeloblasts and chronic myelomonocytic leukaemia II). Transfuze a hematologie dnes. Praha: Česká lékařská společnost J.E.Purkyně, 2013, vol. 19, No 3, p. 125-133. ISSN 1213-5763.
      Name (in English): Initial experience of Czech MDS Group with 5-azacytidine in patients with high risk myelodysplastic syndromes (IPSS intermediate II and high), acute myeloid leukaemia with less than 30% myeloblasts and chronic myelomonocytic leukaemia II
      RIV/00216224:14110/13:00071681 Article in a journal. Oncology and haematology. Czech. Czech Republic.
      Jonášová, A. (203 Czech Republic) -- Čermák, J. (203 Czech Republic) -- Červinek, Libor (203 Czech Republic, belonging to the institution) -- Nováková, L. (203 Czech Republic) -- Bělohlávková, P. (203 Czech Republic) -- Vondráková, J. (203 Czech Republic) -- Černá, O. (203 Czech Republic) -- Sýkora, M. (203 Czech Republic) -- Seifertová, N. (203 Czech Republic) -- Walterová, L. (203 Czech Republic) -- Libiger, J. (203 Czech Republic) -- Hochová, I. (203 Czech Republic) -- Ullrychová, J. (203 Czech Republic) -- Rohoň, P. (203 Czech Republic) -- Obernauerová, J. (203 Czech Republic) -- Schutzová, M. (203 Czech Republic) -- Vozobulová, V. (203 Czech Republic) -- Poláčková, H. (203 Czech Republic) -- Kačmářová, K. (203 Czech Republic) -- Mužík, Jan (203 Czech Republic, guarantor, belonging to the institution)
      Keywords in English: Azacytidine; Myelodysplastic syndromes; Overall survival; Prognostic factors; Therapy
      Reviewed: yes
      Changed by: Soňa Böhmová, učo 232884. Changed: 31/1/2014 17:08.
      More: https://is.muni.cz/publication/1162116/en
    5. Ruxolitinib v léčbě primární myelofibrózy (Ruxolitinib in the treatment of primary myelofibrosis)
      ČERVINEK, Libor and Michael DOUBEK. Ruxolitinib v léčbě primární myelofibrózy (Ruxolitinib in the treatment of primary myelofibrosis). Farmakoterapie. Praha: Farmakon Press, spol. s r.o., 2013, Neuveden, No 2, p. 120-123. ISSN 1801-1209.
      URL
      Name in Czech: Ruxolitinib v léčbě primární myelofibrózy
      Name (in English): Ruxolitinib in the treatment of primary myelofibrosis
      RIV/00216224:14740/13:00069022 Article in a journal. Oncology and haematology. Czech. Czech Republic.
      Červinek, Libor (203 Czech Republic, belonging to the institution) -- Doubek, Michael (203 Czech Republic, guarantor, belonging to the institution)
      Keywords in English: Janus kinases; primary myelofibrosis; ruxolitinib
      Reviewed: yes
      Changed by: Olga Křížová, učo 56639. Changed: 3/4/2014 06:25.
      More: https://is.muni.cz/publication/1119394/en
    6. Účinnost léčby anagrelidem u nemocných s Ph-negativními myeloproliferativními chorobami: Ovlivnění výskytu trombózy ve výstupech Registru pacientů s diagnozou esencialni trombocytemie a trombocytemie provazejici jine myeloproliferativni onemocneni lecenych Thromboreductinem® ke konci roku 2012 (The effectiveness of anagrelide treatment in patients with Ph-negative myeloproliferative diseases: Influence on the incidence of thrombosis in the data from the Registry of patients with essential thrombocythemia and thrombocythemia associated with othe)
      PENKA, Miroslav, J. SCHWARZ, Petra OVESNÁ, Libor ČERVINEK, P. DULÍČEK, D. POSPÍŠILOVÁ, Jarmila KISSOVÁ and Tomáš PAVLÍK. Účinnost léčby anagrelidem u nemocných s Ph-negativními myeloproliferativními chorobami: Ovlivnění výskytu trombózy ve výstupech Registru pacientů s diagnozou esencialni trombocytemie a trombocytemie provazejici jine myeloproliferativni onemocneni lecenych Thromboreductinem® ke konci roku 2012 (The effectiveness of anagrelide treatment in patients with Ph-negative myeloproliferative diseases: Influence on the incidence of thrombosis in the data from the Registry of patients with essential thrombocythemia and thrombocythemia associated with othe). Vnitřní lékařství. Brno: Ambit Media a.s., 2013, vol. 59, No 6, p. 516-531. ISSN 0042-773X.
      Name (in English): The effectiveness of anagrelide treatment in patients with Ph-negative myeloproliferative diseases: Influence on the incidence of thrombosis in the data from the Registry of patients with essential thrombocythemia and thrombocythemia associated with othe
      RIV/00216224:14110/13:00071672 Article in a journal. Oncology and haematology. Czech. Czech Republic.
      Penka, Miroslav (203 Czech Republic, guarantor, belonging to the institution) -- Schwarz, J. (203 Czech Republic) -- Ovesná, Petra (203 Czech Republic, belonging to the institution) -- Červinek, Libor (203 Czech Republic, belonging to the institution) -- Dulíček, P. (203 Czech Republic) -- Pospíšilová, D. (203 Czech Republic) -- Kissová, Jarmila (203 Czech Republic, belonging to the institution) -- Pavlík, Tomáš (203 Czech Republic, belonging to the institution)
      Keywords in English: Anagrelide (Thromboreductin); Myeloproliferative disorders; Patient registry; Thrombosis
      Reviewed: yes
      Changed by: Soňa Böhmová, učo 232884. Changed: 31/1/2014 16:20.
      More: https://is.muni.cz/publication/1162098/en
    7. Vyšetření mutačního statut p53 v souboru pacientů s MDS před léčbou a v rámci terapie azacytidinem
      PAVLOVÁ, Šárka, Libor ČERVINEK and Michael DOUBEK. Vyšetření mutačního statut p53 v souboru pacientů s MDS před léčbou a v rámci terapie azacytidinem. In Zimní setkání, Zámek Loučeň. 2013.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 6/4/2013 13:58.
      More: https://is.muni.cz/publication/1094895/en

    2012

    1. Efficacy of rituximab in primary immune thrombocytopenia: an analysis of adult pretreated patients from everyday hematological practice
      ČERVINEK, Libor, Olga CERNA, Miroslav ČANIGA, Eva KONIROVA, Antonín HLUŠÍ, Martin SIMKOVIC, Zdeněk POSPÍŠIL, Jaroslav CERMAK, Tomáš KOZÁK, Jiří MAYER and Michael DOUBEK. Efficacy of rituximab in primary immune thrombocytopenia: an analysis of adult pretreated patients from everyday hematological practice. International journal of hematology. Tokyo, Japan: Springer, 2012, vol. 96, No 5, p. 594-599. ISSN 0925-5710. Available from: https://dx.doi.org/10.1007/s12185-012-1206-7.
      URL
      RIV/00216224:14740/12:00058699 Article in a journal. Oncology and haematology. English. Japan.
      Červinek, Libor (203 Czech Republic, guarantor, belonging to the institution) -- Cerna, Olga (203 Czech Republic) -- Čaniga, Miroslav (203 Czech Republic) -- Konirova, Eva (203 Czech Republic) -- Hluší, Antonín (203 Czech Republic) -- Simkovic, Martin (203 Czech Republic) -- Pospíšil, Zdeněk (203 Czech Republic, belonging to the institution) -- Cermak, Jaroslav (203 Czech Republic) -- Kozák, Tomáš (203 Czech Republic) -- Mayer, Jiří (203 Czech Republic, belonging to the institution) -- Doubek, Michael (203 Czech Republic, belonging to the institution)
      Keywords in English: Adults; Immune thrombocytopenia; Response rate; Rituximab
      International impact: yes
      Reviewed: yes
      Changed by: Olga Křížová, učo 56639. Changed: 10/4/2013 14:40.
      More: https://is.muni.cz/publication/1079733/en
    2. Laparoskopická splenektomie (Laparoscopic splenectomy)
      KALA, Zdeněk, Vladimír PROCHÁZKA and Libor ČERVINEK. Laparoskopická splenektomie (Laparoscopic splenectomy). Endoskopie. Praha: Nadace Sakura Bohemica, 2012, vol. 21, No 1, p. 5-7. ISSN 1211-1074.
      Name (in English): Laparoscopic splenectomy
      RIV/00216224:14110/12:00068792 Article in a journal. Surgery including transplantology. Czech. Czech Republic.
      Kala, Zdeněk (203 Czech Republic, guarantor, belonging to the institution) -- Procházka, Vladimír (203 Czech Republic, belonging to the institution) -- Červinek, Libor (203 Czech Republic, belonging to the institution)
      Keywords in English: Corticosteroid therapy; Intravenous immunoglobulins; Laparoscopy; Splenectomy; Thrombocytopenia
      Reviewed: yes
      Changed by: Soňa Böhmová, učo 232884. Changed: 16/7/2013 15:18.
      More: https://is.muni.cz/publication/1115117/en

    2011

    1. Parciální regrese ložisek Erdheimovy-Chesterovy nemoci v CNS po léčbě 2-chlorodeoxyadenosinem a jejich kompletní vymizení při léčbě lenalidomidem (Partial Regression of CNS Lesions of Erdheim-Chester Disease after Treatment with 2-chlorodeoxadenosine and Their Full Remission Following Treatment with Lenalidomide)
      ADAM, Zdeněk, Andrea ŠPRLÁKOVÁ-PUKOVÁ, Zdeněk ŘEHÁK, R. KOUKALOVÁ, Petr SZTURZ, Marta KREJČÍ, Luděk POUR, Lenka ZAHRADOVÁ, Libor ČERVINEK, Leoš KŘEN, Mojmír MOULIS, Markéta HERMANOVÁ, Marek MECHL, Jiří PRÁŠEK, Roman HÁJEK, Zdeněk KRÁL and Jiří MAYER. Parciální regrese ložisek Erdheimovy-Chesterovy nemoci v CNS po léčbě 2-chlorodeoxyadenosinem a jejich kompletní vymizení při léčbě lenalidomidem (Partial Regression of CNS Lesions of Erdheim-Chester Disease after Treatment with 2-chlorodeoxadenosine and Their Full Remission Following Treatment with Lenalidomide). Klinická onkologie. 2011, vol. 24, No 5, p. 367-381. ISSN 0862-495X.
      Name (in English): Partial Regression of CNS Lesions of Erdheim-Chester Disease after Treatment with 2-chlorodeoxadenosine and Their Full Remission Following Treatment with Lenalidomide
      RIV/00216224:14110/11:00054656 Article in a journal. Oncology and haematology. Czech. Czech Republic.
      Adam, Zdeněk (203 Czech Republic, guarantor, belonging to the institution) -- Šprláková-Puková, Andrea (203 Czech Republic, belonging to the institution) -- Řehák, Zdeněk (203 Czech Republic, belonging to the institution) -- Koukalová, R. (203 Czech Republic) -- Szturz, Petr (203 Czech Republic, belonging to the institution) -- Krejčí, Marta (203 Czech Republic, belonging to the institution) -- Pour, Luděk (203 Czech Republic, belonging to the institution) -- Zahradová, Lenka (203 Czech Republic, belonging to the institution) -- Červinek, Libor (203 Czech Republic, belonging to the institution) -- Křen, Leoš (203 Czech Republic, belonging to the institution) -- Moulis, Mojmír (203 Czech Republic, belonging to the institution) -- Hermanová, Markéta (203 Czech Republic, belonging to the institution) -- Mechl, Marek (203 Czech Republic, belonging to the institution) -- Prášek, Jiří (203 Czech Republic, belonging to the institution) -- Hájek, Roman (203 Czech Republic, belonging to the institution) -- Král, Zdeněk (203 Czech Republic, belonging to the institution) -- Mayer, Jiří (203 Czech Republic, belonging to the institution)
      Keywords in English: Erdheim-Chester disease; juvenile xanthogranuloma; osteosclerosi; skeletal scinigraphy; PET-CT; lenalidomide; 2-chlorodeoxyadenosine; cladribin; retroperitoneal fibrosis
      Reviewed: yes
      Changed by: Mgr. Lucie Jarošová, DiS., učo 205746. Changed: 7/4/2015 14:29.
      More: https://is.muni.cz/publication/964405/en
    2. Úspěšná léčba Erdheimovy-Chesterovy nemoci chemoterapií obsahující 2-chlorodeoxyadenosin. Popis dvou případů a přehled literatury (Successful treatment of Erdheim-Chester disease by 2-chlorodoxyadenosine-based chemotherapy. Two case studies and a literature review.)
      ADAM, Zdeněk, R. KOUKALOVÁ, Andrea ŠPRLÁKOVÁ-PUKOVÁ, Z. ŘEHÁK, Libor ČERVINEK, Petr SZTURZ, Marta KREJČÍ, Luděk POUR, Lenka ZAHRADOVÁ, Mojmír MOULIS, Jiří PRÁŠEK, Richard CHALOUPKA, Roman HÁJEK and Jiří MAYER. Úspěšná léčba Erdheimovy-Chesterovy nemoci chemoterapií obsahující 2-chlorodeoxyadenosin. Popis dvou případů a přehled literatury (Successful treatment of Erdheim-Chester disease by 2-chlorodoxyadenosine-based chemotherapy. Two case studies and a literature review.). Vnitřní lékařství. 2011, vol. 57, No 6, p. 576-589. ISSN 0042-773X.
      Name (in English): Successful treatment of Erdheim-Chester disease by 2-chlorodoxyadenosine-based chemotherapy. Two case studies and a literature review.
      RIV/00216224:14110/11:00056974 Article in a journal. Other fields of internal medicine. Czech. Czech Republic.
      Adam, Zdeněk (203 Czech Republic, guarantor, belonging to the institution) -- Koukalová, R. (203 Czech Republic) -- Šprláková-Puková, Andrea (203 Czech Republic, belonging to the institution) -- Řehák, Z. (203 Czech Republic) -- Červinek, Libor (203 Czech Republic, belonging to the institution) -- Szturz, Petr (203 Czech Republic, belonging to the institution) -- Krejčí, Marta (203 Czech Republic, belonging to the institution) -- Pour, Luděk (203 Czech Republic, belonging to the institution) -- Zahradová, Lenka (203 Czech Republic, belonging to the institution) -- Moulis, Mojmír (203 Czech Republic) -- Prášek, Jiří (203 Czech Republic) -- Chaloupka, Richard (203 Czech Republic) -- Hájek, Roman (203 Czech Republic, belonging to the institution) -- Mayer, Jiří (203 Czech Republic, belonging to the institution)
      Keywords in English: Erdheim-Chester disease; juvenile xanthogranuloma; PET-CT; imagination; bone scan; 2-chlorodeoxyadenosine; cladribine; cyclophosphamide; dexamethasone; fewer of unknown origin; osteosclerosis; hyperostosis; osteoporosis; ertroperitoneal fibrosis
      Reviewed: yes
      Changed by: Mgr. Michal Petr, učo 65024. Changed: 30/9/2011 11:23.
      More: https://is.muni.cz/publication/945633/en

    2010

    1. Do we know an ideal patient with immune thrombocytopenia for rituximab treatment?
      ČERVINEK, Libor, Jiří MAYER and Michael DOUBEK. Do we know an ideal patient with immune thrombocytopenia for rituximab treatment? In Haematologica, 15th Congress of the European Hematology Association, Spain, Barcelona, 2010. 2010. ISSN 0390-6078.
      Oncology and haematology. English. Czech Republic.
      Type of participation: active participation (giving a lecture, organization, etc.)
      International impact: yes
      Reviewed: yes
      Changed by: RNDr. Jitka Malčíková, Ph.D., učo 14364. Changed: 12/8/2010 13:42.
      More: https://is.muni.cz/publication/893852/en
    2. Imunitní trombocytopenie, diagnostika, klasifikace, diferenciální diagnostika
      ČERVINEK, Libor. Imunitní trombocytopenie, diagnostika, klasifikace, diferenciální diagnostika. Vnitřní Lékařství. 2010, vol. 56, suppl.1, p. S75-S77, 3 pp. ISSN 0042-773X.
      Oncology and haematology. Czech. Czech Republic.
      Changed by: Jitka Firešová, učo 112925. Changed: 18/1/2011 07:41.
      More: https://is.muni.cz/publication/920752/en
    3. Terapie imunitní trombocytopenické purpury ve světle nejnovějších doporučení
      ČERVINEK, Libor and Jiří MAYER. Terapie imunitní trombocytopenické purpury ve světle nejnovějších doporučení. Farmakoterapie. 2010, vol. 6, No 2, p. 164-169. ISSN 1801-1209.
      Oncology and haematology. Czech. Czech Republic.
      Changed by: Mgr. Michal Petr, učo 65024. Changed: 17/1/2012 15:42.
      More: https://is.muni.cz/publication/886168/en

    2009

    1. Idiopatická trombocytopenická purpura - patogeneze, moderní léčba a analýza prevalence, diagnostiky a terapie nemoci v Jihomoravském kraji (Idiopathic thrombocytopenic purpura - pathogenesis, modern therapy, and an analysis of its prevalence, diagnostics and therapy in the South Moravian Region)
      ČERVINEK, Libor, Michael DOUBEK and Jiří MAYER. Idiopatická trombocytopenická purpura - patogeneze, moderní léčba a analýza prevalence, diagnostiky a terapie nemoci v Jihomoravském kraji (Idiopathic thrombocytopenic purpura - pathogenesis, modern therapy, and an analysis of its prevalence, diagnostics and therapy in the South Moravian Region). Transfuze a hematologie dnes. 2009, vol. 15, No 1, p. 23-30. ISSN 1213-5763.
      Name (in English): Idiopathic thrombocytopenic purpura - pathogenesis, modern therapy, and an analysis of its prevalence, diagnostics and therapy in the South Moravian Region

      Changed by: Jitka Drncová, učo 109799. Changed: 3/9/2009 14:24.
      More: https://is.muni.cz/publication/843072/en

    2007

    1. SLE s hematologickými komplikacemi
      ČERVINEK, Libor, Zdeněk FOJTÍK and Zdeněk KOŘÍSTEK. SLE s hematologickými komplikacemi. In XXI. Olomoucké hematologické dny s mezinárodní účastí. 1st ed. Olomouc: Rubico, 2007, p. 80. ISBN 978-80-7346-078-5.
      URL
      Changed by: Libuše Šimečková, učo 103602. Changed: 15/1/2008 22:18.
      More: https://is.muni.cz/publication/749096/en

    2004

    1. Brief Report. Lagerhans Cell Histiocytosis With Central Nervous System Involvement: Up by FDG-PET During Treatment With Cladribine.
      BÜCHLER, Tomáš, Libor ČERVINEK, O. BĚLOHLÁVEK, KANTOROVÁ, Marek MECHL, Tomáš NEBESKÝ, Jiří VORLÍČEK and Zdeněk ADAM. Brief Report. Lagerhans Cell Histiocytosis With Central Nervous System Involvement: Up by FDG-PET During Treatment With Cladribine. Pediatr Blood Cancer. 2004, No 43, p. 1-3.
      Changed by: Marta Casková, učo 446. Changed: 1/2/2005 15:07.
      More: https://is.muni.cz/publication/565616/en
    2. Langerhans Cell Histiocytosis With Central Nervous System
      BÜCHLER, Tomáš. Langerhans Cell Histiocytosis With Central Nervous System. 2004, 1-3. Pediatr Blood Cancer, 43.
      Changed by: Jitka Halouzková, učo 1873. Changed: 4/3/2005 11:22.
      More: https://is.muni.cz/publication/568611/en
Displayed: 4/5/2024 01:32